Weekly Oral Helicase-Primase Inhibitor Programs' Early Data Potentially Supportive of First New Treatment for Recurrent ...

DSA membership jumped from 80,000 in October to over 90,000 by November. The Las Vegas chapter gained 200 members between ...

Investigational Treatment Regimen Could Expand Options for Virologically Suppressed Adults –– Positive Phase 3 Results from Both ARTISTRY-2 and ARTISTRY-1 Trials will Form the Basis of Regulatory ...

The Delhi High Court's division bench has upheld an interim order stopping Ganraj Enterprises, a Maharashtra-based maker of ...

Disney has escalated its fight over AI training data. The company sent Google a cease-and-desist letter on Wednesday, accusing the tech giant of copying its copyrighted material “on a massive scale” ...

Amazon did not storm the American fashion industry with splashy runway shows or celebrity creative directors. It quietly ...

If you look puzzled, or answer in your clearest English, “I’m sorry, I don’t understand, kid, I’m from Minnesota,” he will call in the troops: “Marek! Krzysztof! Piotr! Chodzi tu!” Each kid has a deck ...

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

As antibiotic-resistant infections rise and are projected to cause up to 10 million deaths per year by 2050, scientists are looking to bacteriophages, viruses that infect bacteria, as an alternative.

France's state-owned utility EDF will cap the cost of building six new nuclear reactors at 72.8 billion euros ($85.29 billion ...